Is It Wise to Retain Henry Schein (HSIC) in Your Portfolio Now?
Henry Schein(HSIC) ZACKS·2024-07-12 14:36Hims & Hers Health's earnings are expected to surge 281.8% in 2024 compared with the industry's 15.7% growth. HIMS' earnings surpassed estimates in three of the trailing four quarters and missed in one, delivering an average surprise of 79.2%. Its shares have surged 131% against the industry's 27.1% decline in the past year. HIMS sports a Zacks Rank #1 (Strong Buy) at present. You can see the complete list of today's Zacks #1 Rank stocks here. Haemonetics, sporting a Zacks Rank #1 at present, has an estimat ...